Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01514591 · ClinicalTrials.gov registry record
Thromboelastography in Non-elective Cesarean Delivery
A clinical trial of Bleeding, sponsored by Stanford University.
- Completed
- Registry status
- 33
- Enrollment target
- 1
- Study location
NCT01514591: Completed study of Bleeding, sponsored by Stanford University.
NCT01514591 is a study of Bleeding that has completed, run by Stanford University. The registered enrollment target is 33 participants, below the 1,483-participant average among 23 other Bleeding trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01514591, a study of Bleeding, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to assess the coagulation changes that occur in laboring patients undergoing non-elective (intrapartum)Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.
Conditions Studied
Study Locations (1)
California
- Lucile Packard Children's Hospital - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01514591
The ClinicalTrials.gov registry entry for NCT01514591 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,483-participant average among 23 other Bleeding trials with a reported enrollment target (98% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bleeding appearing as the primary indexed condition, and to 0 interventions.
NCT01514591 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01514591 about?
NCT01514591 is a clinical study titled "Thromboelastography in Non-elective Cesarean Delivery". The purpose of the study is to assess the coagulation changes that occur in laboring patients undergoing non-elective (intrapartum)Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and...
What is the current status of trial NCT01514591?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2011-08. Estimated completion is 2013-06.
What conditions does trial NCT01514591 study?
This clinical trial studies the following conditions: Bleeding.
Who is sponsoring clinical trial NCT01514591?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01514591 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bleeding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
RECRUITING · Phase 2
-
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
RECRUITING
-
Quantra Point-of-Care Hemostasis Monitoring
RECRUITING · NA
-
Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device
RECRUITING · Phase 4
-
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
RECRUITING · Phase 3
-
Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders
RECRUITING
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.